In the early 40s, and perhaps even earlier, it is important for women and their health care team to start discussing ...
And while lifestyle choices still matter, the underlying cause isn’t willpower. It’s physiology.
LONDON, Dec 9 (Reuters) - Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly (LLY.N), opens new tab and Novo Nordisk (NOVOb.CO), opens new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results